Enrichment Guidance To Prod Sponsors Toward Prospective Patient Stratification

The sensitivity and specificity of the target identification could determine size of the off-target population, CDER senior statistical advisor Robert O’Neill says at DIA/FDA meeting on revitalizing R&D.